Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Capstone Therapeutics Corp. (CAPS) had Normalized Pre-Tax Income of $-0.70M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$12.85M |
|
$-0.70M |
|
$9.72M |
|
$3.13M |
|
$13.11M |
|
$-0.26M |
|
$-0.44M |
|
$-0.70M |
|
|
Normalized Pre-Tax Income |
$-0.70M |
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.70M |
|
$-0.26M |
|
$-0.15M |
|
5.41M |
|
5.41M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$16.53M |
|
$1.47M |
|
$35.35M |
|
$51.88M |
|
$16.97M |
|
$5.83M |
|
$8.64M |
|
$25.61M |
|
$26.24M |
|
$2.93M |
|
$26.27M |
|
5.41M |
|
| Cash Flow Statement Financials | |
$-3.99M |
|
$-0.00M |
|
$4.76M |
|
$0.01M |
|
$0.77M |
|
$0.76M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.97 |
|
-- |
|
-- |
|
0.18 |
|
0.66 |
|
24.35% |
|
-2.02% |
|
-2.02% |
|
-- |
|
-5.45% |
|
-5.45% |
|
$-3.99M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
1.01 |
|
2.34 |
|
38.42 |
|
-2.67% |
|
-23.92% |
|
-1.35% |
|
-2.18% |
|
$4.86 |
|
$-0.74 |
|
$-0.74 |
|